Event Brief
FDA seeks input on testosterone therapy for menopausal women
By The BriefBrief · Sources (2)
Filed: Sep 17, 2026 at 12:09 PM ET
Summary: The FDA requested public input ahead of a hearing examining testosterone therapy as its use by menopausal women rises. Hundreds of submissions were received, including many women describing improved libido, energy levels, and quality of life while on testosterone.
WHO: U.S. Food and Drug Administration (FDA)
WHAT: FDA requested public input ahead of a hearing on testosterone therapy use by menopausal women.
WHEN: Sep 17, 2026 at 11:10 AM ET
WHERE: USA
WHY: Cause not yet established.
How this brief is built: The BriefBrief uses multi-source information fusion to correlate reporting across sources, identify related developments, and continuously update a structured WHO, WHAT, WHEN, WHERE and WHY event picture. Pattern arcs, source analysis, and velocity indicators provide deeper analysis in our MI Console.
Kosovo officials call Thaci war-crimes conviction unjust
Kosovo
Sep 17, 2026 at 12:09 PM ET
Romania’s president nominates MEP to form government
Romania
Sep 17, 2026 at 12:09 PM ET
Kennedy Center to close temporarily for seven days
Kennedy Center
Sep 17, 2026 at 12:07 PM ET
Mbappé explains his Ceuta solidarity message
Europe
Sep 17, 2026 at 12:07 PM ET
